Form4insider filings, from the source

SEC Form 4 · accession 0001179110-15-000533

NephroGenex, Inc. · NRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Joshua Ruch
10% Owner
Habib Kairouz
10% Owner
Mark Leschly
10% Owner
RMV V, L.L.C.
10% Owner
Period of report
Jan 2, 2015
Accepted (ET)
Jan 6, 2015 · 5:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001338095

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F7Jan 2, 2015S88,000$10.8319D1,238,826ISee Footnote
Common StockF3,F4,F7Jan 5, 2015S164,919$10.5389D1,073,907ISee Footnote
Common StockF5,F6,F7Jan 6, 2015S20,941$9.9011D1,052,966ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses